Trial · NCT00244621
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline to Week 4 in Systolic Blood Pressure (SBP) | Atacand .05 mg | -6.0 | Standard Deviation 9.4 | mm Hg | |
| Mean Change From Baseline to Week 4 in Systolic Blood Pressure (SBP) | Atacand .20 mg | -8.9 | Standard Deviation 9.2 | mm Hg | |
| Mean Change From Baseline to Week 4 in Systolic Blood Pressure (SBP) | Atacand .40 mg | -12.0 | Standard Deviation 8.3 | mm Hg | |
| Mean Change From Baseline to Week 4 in Diastolic Blood Pressure (DBP) | Atacand .05 mg | -5.2 | Standard Deviation 6.7 | mm Hg | |
| Mean Change From Baseline to Week 4 in Diastolic Blood Pressure (DBP) | Atacand .20 mg | -7.9 | Standard Deviation 12.9 | mm Hg | |
| Mean Change From Baseline to Week 4 in Diastolic Blood Pressure (DBP) | Atacand .40 mg | -11.1 | Standard Deviation 9.2 | mm Hg | |
| Change in Albumin/Creatinine (A/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .05 mg | -11.1 | Inter-Quartile Range -42.5 to 33.3 | Percent change | |
| Change in Albumin/Creatinine (A/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .20 mg | -40.6 | Inter-Quartile Range -68.1 to 25.0 | Percent change | |
| Change in Albumin/Creatinine (A/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .40 mg | -50.0 | Inter-Quartile Range -68.9 to 15.8 | Percent change | |
| Change in Protein/Creatinine (P/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .05 mg | 0.0 | Inter-Quartile Range -25.0 to 50.0 | Percent change | |
| Change in Protein/Creatinine (P/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .20 mg | -29.2 | Inter-Quartile Range -50.0 to 0.0 | Percent change | |
| Change in Protein/Creatinine (P/C) Ratio for Each Assigned Dose Level From Baseline to Day 28 | Atacand .40 mg | 0.0 | Inter-Quartile Range -40.7 to 0.0 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00244621/results